Stefan Kleinert

TU Dortmund University — Germany

Medicine · Health Sciences

21h-index1.8kcitations104works11.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(58), Systemic Lupus Erythematosus Research(20), Autoimmune and Inflammatory Disorders Research(20), Chronic Lymphocytic Leukemia Research(15), Monoclonal and Polyclonal Antibodies Research(13)

Publications102 total

A randomized Phase 1b trial evaluating the pharmacodynamics of ilofotase alfa in adults with hypophosphatasia
Journal of Bone and Mineral Research·2025Open Access
Wiederanstieg der Januskinaseinhibitor-Neuverordnungen
Zeitschrift für Rheumatologie·2025Open Access
Discordance between patient and physician reported global disease activity in PsA is associated with mental health—a cross-sectional analysis
Rheumatology International·2025· 1 citedOpen Access
Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review
Frontiers in Medicine·2025· 2 citedOpen Access
RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings
Rheumatology International·2025Open Access
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis – a retrospective analysis from the RHADAR database
Rheumatology International·2025· 3 cited
Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal Registry
Rheumatology and Therapy·2025· 9 citedOpen Access
Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases
BMJ Open·2025Open Access
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study
Frontiers in Immunology·2024· 3 citedOpen Access
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network
Rheumatology International·2024· 4 citedOpen Access
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial
Journal of Medical Internet Research·2024· 15 citedOpen Access
POS0890 LONG-TERM CARDIO-VASCULAR RISK IN PATIENTS WITH RHEUMATIC DISEASES – RESULTS OF A 17 YEAR FOLLOW UP STUDY
Annals of the Rheumatic Diseases·2024
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database
Frontiers in Immunology·2024· 8 citedOpen Access
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
The Lancet·2024· 118 cited
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial (Preprint)
2023Open Access
Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices
Rheumatology International·2023· 5 cited
Eine Applikation für die rheumatologische Versorgung: RheCORD
Aktuelle Rheumatologie·2023
POS0377 ACCURACY OF AN AI-BASED SYMPTOM CHECKER AND AN ONLINE SELF-REFERRAL TOOL IN RHEUMATOLOGY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL
Annals of the Rheumatic Diseases·2023· 2 citedOpen Access
Physical Function of RA patients Tapering Treatment—A Post Hoc Analysis of the Randomized Controlled RETRO Trial
Journal of Clinical Medicine·2023· 2 citedOpen Access
Physical Function of RA patients tapering treatment: A Post-Hoc Analysis of the Randomized Controlled RETRO Trial
Preprints.org·2023· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Georg Schett(20), Axel J. Hueber(18), Martin Feuchtenberger(18), Hans‐Peter Tony(17), Arnd Kleyer(16), Matthias Englbrecht(16), Florian Schuch(15), Monika Ronneberger(13), Bernhard Manger(12), Martin Welcker(12), Karin Manger(11), Rieke Alten(10), Martin Fleck(9), J. Wendler(9), Jürgen Rech(9), Wolfgang Vorbrüggen(9), Peter Bartz‐Bazzanella(9), David Simón(8), Koray Taşçılar(8), Johannes Knitza(8)